Overview, The Global Tissue Engineering Market Size is expected to register a CAGR of 17.84% to reach USD 53,424.00 Million by 2024. Tissue engineering is designed to influence the physical, chemical, and biological environment surrounding the cell population. It is an interdisciplinary field that applies the principle of engineering and life science towards the development of biological products that help improve the functioning of tissues or a whole organ. Tissue engineering provides solutions that can replace or either repair tissue, including transplant, surgical reconstruction, and medical devices., Growing geriatric population, increasing the incidence rate of chronic and infectious diseases, 3D bioprinting emerging as a novel tissue engineering strategy due to its cost efficiency, and an increased focus of companies on tissue engineering-based therapies are expected to enhance the tissue engineering market growth. However, factors such as lack of awareness regarding tissue engineering, lack of skilled professionals, stringent regulatory policies are restraining the market growth., Market Dynamics, The global tissue engineering has been primarily driven by growing geriatric population, increasing the incidence rate of chronic and infectious diseases, 3D bioprinting emerging as a novel tissue engineering strategy due to its cost efficiency, expanded the focus of companies on tissue engineering-based therapies. According to the Office for National Statistics in 2017, approximately 18% and 2.4% of the total population in the UK was aged over 65 years and 85 years, respectively. Hence, increasing geriatric population is positively impacting the growth of the global tissue engineering market. Factors such as lack of awareness regarding tissue engineering, lack of skilled professionals, and stringent regulatory policies are restraining the market growth., Global Tissue Engineering Revenue, by Material, 2018 & 2024 (USD Million), , Sources: MRFR Analysis, Segmentation, The global tissue engineering market is segmented into material and application. Based on material, the market has been divided into nano-fib

Overview

The Global Tissue Engineering Market Size is expected to register a CAGR of 17.84% to reach USD 53,424.00 Million by 2024. Tissue engineering is designed to influence the physical, chemical, and biological environment surrounding the cell population. It is an interdisciplinary field that applies the principle of engineering and life science towards the development of biological products that help improve the functioning of tissues or a whole organ. Tissue engineering provides solutions that can replace or either repair tissue, including transplant, surgical reconstruction, and medical devices.

Growing geriatric population, increasing the incidence rate of chronic and infectious diseases, 3D bioprinting emerging as a novel tissue engineering strategy due to its cost efficiency, and an increased focus of companies on tissue engineering-based therapies are expected to enhance the tissue engineering market growth. However, factors such as lack of awareness regarding tissue engineering, lack of skilled professionals, stringent regulatory policies are restraining the market growth.

Market Dynamics

The global tissue engineering has been primarily driven by growing geriatric population, increasing the incidence rate of chronic and infectious diseases, 3D bioprinting emerging as a novel tissue engineering strategy due to its cost efficiency, expanded the focus of companies on tissue engineering-based therapies. According to the Office for National Statistics in 2017, approximately 18% and 2.4% of the total population in the UK was aged over 65 years and 85 years, respectively. Hence, increasing geriatric population is positively impacting the growth of the global tissue engineering market. Factors such as lack of awareness regarding tissue engineering, lack of skilled professionals, and stringent regulatory policies are restraining the market growth.

Global Tissue Engineering Revenue, by Material, 2018 & 2024 (USD Million)



Sources: MRFR Analysis

Segmentation

The global tissue engineering market is segmented into material and application. Based on material, the market has been divided into nano-fibrous material, biomimetic material, composite material, and nano-composite material. Based on use, the market has been classified as orthopedics, musculoskeletal and spine, skin/integumentary, cancer, dental, cardiology, urology, neurology, cord blood & cell banking, and GI & gynecology. The nano-fibrous material held a market value of 3,625.6 USD Million in 2018.

Key Players

The prominent players in the global tissue engineering industry are Stryker, Allergan, Medtronic, Zimmer, Baxter International, Integra LifeSciences, Organovo Holdings Inc, Cook Medical, DePuy Synthes, and Acelity.

Asia-Pacific Tissue Engineering Market Share, 2018 (%)



Sources: MRFR Analysis

Regional Analysis

The global tissue engineering market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is expected to dominate the market, mainly due to the increasing geriatric population and the availability of advanced healthcare facilities in this region. Factors leading to the growth of tissue engineering market are increasing the number of clinical trials to evaluate the therapeutic potential of products, the rising prevalence of chronic diseases, and growing public awareness related to the therapeutic potency of therapy.

Europe is anticipated to account for the second-largest market share during the forecast period. Factors responsible for market growth in this region are high availability of funds for R&D, and rising support of the government for the life science domain.

Asia-Pacific is estimated to be the fastest-growing region in the global tissue engineering market due to the rising biomaterial-based research, increasing demand for plastic surgeries, growing cancer incidence, and the increasing prevalence of cardiovascular diseases. Japan held a market share of 25.3% in 2018.

The tissue engineering market in the Middle East & Africa accounts for the least share in the during the forecast period. The market is expected to dominate due to the increasing use of tissue engineering for the treatment of various chronic diseases in Saudi Arabia, Kuwait, and the UAE.

The players operating in the global tissue engineering are focusing on product launches, along with expanding their global footprints by entering untapped markets.



In February 2017 , Allergan announced the acquisition of LifeCell Acquisition. Lifecell is known for Accelular dermal matrix and fat grafting products.





In January 2017 , Integra LifeSciences acquired the Codman neurosurgery business from Johnson & Johnson for USD 1045 million to gain the first position in neurosurgical products





In April 2017 , DePuy Synthes announced the acquisition of 3D printing technologies from tissue regeneration systems.



Market Segmentation

Global Tissue Engineering Market, by Material



Nano-Fibrous Material



Biomimetic Material



Composite Material



Nano-Composite Material



Global Tissue Engineering Market, by Application



Orthopedics



Musculoskeletal and Spine



Skin/Integumentary



Cancer, Dental



Cardiology



Urology



Neurology



Cord Blood & Cell Banking



GI & Gynecology



Global Tissue Engineering Market, by Region



Americas



North America



US

Canada





Latin America











Europe



Western Europe



Germany

UK

France

Italy

Spain

Rest of Western Europe





Eastern Europe











Asia-Pacific



China

Japan

India

Australia

South Korea

Rest of Asia-Pacific











Middle East & Africa



Middle East

Africa









Available Additional Customizations

Intended Audience



Tissue Engineering Manufacturers



Healthcare Providers



Research Institutes and Academic Centers



Government Associations



Market Research and Consulting



Frequently Asked Questions (FAQ) :